SY

Shang Yin Xing Ling

Description

Shang Yin Xing Ling

Investor Profile

Shang Yin Xing Ling has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Shang Yin Xing Ling frequently co-invest with?

IDG Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Sherpa Capital Entidad Gestora
Europe, Madrid, Spain, Madrid
Co-Investments: 1
China Cinda Asset Management
Asia, Beijing, China, Beijing
Co-Investments: 1
CC
Asia, Beijing, China, Beijing
Co-Investments: 1

Which angels does Shang Yin Xing Ling often collaborate with?

Shared Deals: 1

What are some of recent deals done by Shang Yin Xing Ling?

Kelun Biotech

Chengdu, Sichuan, China

Kelun Biotech is a biopharmaceutical company.It focuses on the research and development, production and sales of innovative drugs.

BiopharmaBiotechnologyMedical
Series BDec 30, 2022
Amount Raised: $200,000,000